1. Home
  2. EZPW vs XNCR Comparison

EZPW vs XNCR Comparison

Compare EZPW & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

N/A

Current Price

$28.37

Market Cap

1.8B

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$39.88

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EZPW
XNCR
Founded
1989
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
EZPW
XNCR
Price
$28.37
$39.88
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$41.00
★ $42.50
AVG Volume (30 Days)
747.5K
★ 1.6M
Earning Date
11-11-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
29.09
★ 65.36
EPS
★ 1.65
N/A
Revenue
★ $747,954,000.00
$125,576,000.00
Revenue This Year
$8.21
$57.39
Revenue Next Year
$7.16
N/A
P/E Ratio
$17.19
★ N/A
Revenue Growth
2.39
★ 13.65
52 Week Low
$16.50
$10.38
52 Week High
$37.13
$40.60

Technical Indicators

Market Signals
Indicator
EZPW
XNCR
Relative Strength Index (RSI) 40.48 82.27
Support Level $27.73 $11.05
Resistance Level $31.62 N/A
Average True Range (ATR) 1.18 2.23
MACD -0.07 1.16
Stochastic Oscillator 24.53 97.00

Price Performance

Historical Comparison
EZPW
XNCR

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: